Breaking News Instant updates and real-time market news.

ATVI

Activision Blizzard

$45.08

-1.62 (-3.47%)

, TTWO

Take-Two

$108.61

-1.68 (-1.52%)

04:55
06/13/19
06/13
04:55
06/13/19
04:55

Jefferies to host company meetings at conference

Jefferies Hosted Company Meetings at E3 2019 will be held in Los Angeles on June 11-13.

ATVI

Activision Blizzard

$45.08

-1.62 (-3.47%)

TTWO

Take-Two

$108.61

-1.68 (-1.52%)

EA

Electronic Arts

$92.66

-1.86 (-1.97%)

MSFT

Microsoft

$131.48

-0.62 (-0.47%)

HEAR

Turtle Beach

$10.17

-0.06 (-0.59%)

NTDOY

Nintendo

$0.00

(0.00%)

  • 13

    Jun

  • 13

    Jun

  • 14

    Jun

  • 17

    Jun

  • 20

    Jun

  • 23

    Jun

  • 10

    Jul

  • 06

    Aug

  • 13

    Nov

ATVI Activision Blizzard
$45.08

-1.62 (-3.47%)

06/07/19
SBSH
06/07/19
INITIATION
Target $47
SBSH
Neutral
Activision Blizzard initiated with a Neutral at Citi
Citi analyst Jason Bazinet started Activision Blizzard with a Neutral rating and $47 price target. The analyst believes consensus estimates are at the right level and that the valuation looks fair at current share levels.
06/06/19
06/06/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Apple (AAPL) initiated with an Outperform at Evercore ISI. 2. Chegg (CHGG) initiated with a Buy at Needham. 3. Cidara Therapeutics (CDTX) initiated with an Outperform at Oppenheimer. 4. Corteva (CTVA) initiated with a Market Perform at Bernstein. 5. Electronic Arts (EA) initiated with a Buy at Nomura Instinet while Activision Blizzard (ATVI) was initiated with a Neutral. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/06/19
NOMU
06/06/19
INITIATION
Target $120
NOMU
Buy
Electronic Arts initiated with a Buy at Nomura Instinet
Nomura Instinet analyst Andrew Marok last night initiated coverage of Electronic Arts (EA) with a Buy rating and $120 price target. The analyst also started Activision Blizzard (ATVI) with a Neutral rating. Electronic Arts is well positioned to capitalize on trends in the broader gaming industry, Marok tells investors in a research note. The company's subscription service is scaling well and is expanding to new platforms, adds the analyst. Further, he views Apex Legends as a new growth driver for EA.
06/06/19
NOMU
06/06/19
INITIATION
Target $49
NOMU
Neutral
Activision Blizzard initiated with a Neutral at Nomura Instinet
Nomura Instinet analyst Andrew Marok last night initiated coverage of Activision Blizzard with a Neutral rating and $49 price target. The company's near-term release roadmap does not appear to provide many opportunities for "notable upside," especially at Blizzard, Marok tells investors in a research note. Outside of "dependable releases" such as the yearly Call of Duty title and semi-annual World of Warcraft expansion, Activision's frontline product pipeline is at a "low point," says the analyst. As such, he sees limited near-term catalysts for the shares.
TTWO Take-Two
$108.61

-1.68 (-1.52%)

05/17/19
BARD
05/17/19
NO CHANGE
BARD
Sony, Microsoft JV a 'surprsing turn' in 'battle for living room,' says Baird
Baird analyst Colin Sebastian said he views the joint venture pact between competitors Microsoft (MSFT) and Sony (SNE) on cloud-based gaming services as both "surprising" and a validation of the emerging market for streaming. The two companies clearly view video games as strategically important enough to put aside their intense competition and see Google (GOOGL) as a legitimate competitor and the Stadia streaming platform as a credible threat, said Sebastian, who added that he does not believe this means Sony and Microsoft will forego their separate console hardware platforms. He also believes that video game developers and publishers should benefit from the intensifying battle among platform companies for share of the game market and the "living room audience." Publicly traded game makers include Activision Blizzard (ATVI), Electronic Arts (EA) and Take-Two (TTWO).
06/04/19
06/04/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Netflix (NFLX) upgraded to Buy from Hold at Loop Capital with analyst Alan Gould saying Netflix has built an "unstoppable lead" in subscription video streaming while the company's margin opportunity is expanding as it increasingly becomes a content producer, distributor and retailer. 2. Wingstop (WING) upgraded to Buy from Hold at Stifel with analyst Chris O'Cull saying the company's system sales growth will remain in mid to high teens for the foreseeable future and generate higher cash flows from increased average unit volumes thanks to its national advertising and digital ordering initiatives. 3. National Beverage (FIZZ) upgraded to Neutral from Sell at UBS with analyst Sean King citing valuation. 4. Take-Two (TTWO) upgraded to Market Perform from Underperform at BMO Capital with analyst Gerrick Johnson with the threat of an economic downturn, video game stocks will be increasingly seen as "safe havens for investors." 5. Mirati Therapeutics (MRTX) upgraded to Buy from Neutral at Citi with analyst Yigal Nochomovitz saying he believes Mirati's KRAS G12Ci has potential to exceed AMG510's 50% overall response rate in non-small cell lung cancer. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/04/19
BMOC
06/04/19
UPGRADE
Target $110
BMOC
Market Perform
Take-Two upgraded to Market Perform from Underperform at BMO Capital
BMO Capital analyst Gerrick Johnson upgraded Take-Two Interactive to Market Perform from Underperform and raised his price target for the shares to $110 from $95. With the threat of an economic downturn, video game stocks will be increasingly seen as "safe havens for investors," Johnson tells investors in a research note. As a result, he expects the sector to receive an elevation of valuation multiples. Further, Take-Two has a "robust pipeline and remains a perceived target for acquisition," adds the analyst.
05/17/19
BMOC
05/17/19
NO CHANGE
Target $95
BMOC
Underperform
Take-Two price target raised to $95 from $80 at BMO Capital
BMO Capital analyst Gerrick Johnson raised his price target on Take-Two to $95 after its above-consensus Q4 earnings, saying that while net bookings missed expectations, lower-than-expected internal royalties drove the bottom-line beat. The analyst notes that the company's core titles like NBA 2K and GTA Online have shown continued strength, but also views the performance of Red Dead Redemption 2 as disappointing. Johnson also keeps his Underperform rating on the stock, warning that monetization of Red Dead Redemption could fall below current expectations with added concern about the potential changes in the video game industry driving lower valuation multiples.
EA Electronic Arts
$92.66

-1.86 (-1.97%)

06/07/19
SBSH
06/07/19
INITIATION
Target $102
SBSH
Neutral
Electronic Arts initiated with a Neutral at Citi
Citi analyst Jason Bazinet started Electronic Arts with a Neutral rating and $102 price target. The analyst believes the company is positioned to meet expectations for total bookings in fiscal 2020 but he finds the stock fairly valued at current levels.
06/12/19
RHCO
06/12/19
NO CHANGE
Target $107
RHCO
Buy
SunTrust 'comfortable' with Electronic Arts' FY20 model after E3 presentation
SunTrust analyst Matthew Thornton kept his Buy rating and $107 price target on Electronic Arts after its E3 presentation yesterday, saying that "net-net", he remains "very comfortable" with his FY20 assumptions even though the out-year slate visibility around Battlefield, Titanfall, UFC, Motive, and other titles remains "low". The analyst cites the company's continued forecast of $300M-$400M in revenue from Apex Legends and 6M-8M units sales for its upcoming Jedi Fallen Order game, but sees a slight decline in Electronic Arts' sports title sales due to comping Fifa World Cup.
MSFT Microsoft
$131.48

-0.62 (-0.47%)

06/12/19
WEDB
06/12/19
NO CHANGE
Target $155
WEDB
Outperform
Microsoft momentum not slowing down, says Wedbush
Wedbush analyst Daniel Ives believes Microsoft (MSFT) remains in an "enviable position" heading into the rest of 2019 and 2020 on the heels of its cloud success and is firing on all cylinders around its Office 365 and Azure strategic vision based on his recent checks. So far in the June quarter the analyst is seeing a "clear acceleration" of larger and more strategic enterprise cloud deals as believes "Redmond is poised to win the lion's share" of the next phase of cloud deployments versus Amazon (AMZN). The shift to cloud is a major secular trend that is significantly benefiting Microsoft in the field and should continue its momentum heading into the next 12-18 months, he contends. Ives reiterates an Outperform rating and $155 price target on Microsoft's shares.
06/12/19
NOMU
06/12/19
NO CHANGE
Target $33
NOMU
Buy
AMD has 'ample opportunity' to drive further growth, says Nomura Instinet
Nomura Instinet analyst David Wong believes AMD's (AMD) "strong" 7nm product pipeline and recent next-generation gaming console wins could help it to maintain its microprocessor momentum and support its "semi-custom" revenue stream. In addition, AMD has "ample opportunity" to drive further growth through market share gains in discrete GPUs for personal computers and continued penetration of the market for datacenter GPUs and accelerators, Wong tells investors in a research note. He reiterates a Buy rating on the shares with a $33 price target. He highlights the company's gaming wins with Microsoft (MSFT), Google (GOOG, GOOGL), and Sony (SNE).
06/06/19
WELS
06/06/19
NO CHANGE
Target $145
WELS
Outperform
Microsoft Azure's growth still not fully appreciated, says Wells Fargo
Noting that Amazon Web Services (AMZN) entered the cloud computing market several years ahead of Microsoft (MSFT), Wells Fargo analyst Philip Winslow says that the latter has experienced more rapid revenue growth, creating a sizeable differential between Azure's and AWS's growth rates while simultaneously closing the dollar revenue gap over time. Although investors have turned more positive on Microsoft Azure, the analyst believes the full multi-year impact of Azure's growth potential is still not properly reflected in consensus estimates for Microsoft. He reiterates an Outperform rating and $145 price target on Microsoft's shares.
06/06/19
DADA
06/06/19
NO CHANGE
Target $9
DADA
Buy
Cloudera price target lowered to $9 from $23 at DA Davidson
DA Davidson analyst Rishi Jaluria lowered his price target on Cloudera (CLDR) to $9 after its "disastrous" quarter with a reset of the company's recurring revenue expectations, resignation of its CEO, and weak bookings, as customers await the release of Cloudera Data Platform, or CDP. The analyst also points to Cloudera's higher churn, and increased competitiveness from Amazon's (AMZN) AWS, Microsoft's (MSFT) Azure, and Google's (GOOGL) GCP impacting the quarter. Jaluria cuts his FY21 EPS view to (19c) from 22c but maintains his Buy rating on Cloudera, citing his "glimmer of hope" that the company can reaccelerate growth with CDP or that either a private equity firm or IBM (IBM) would acquire it given the reduced 1.8-times enterprise value to expected 2020 revenue valuation.
HEAR Turtle Beach
$10.17

-0.06 (-0.59%)

03/15/19
LSCM
03/15/19
NO CHANGE
Target $20
LSCM
Buy
Turtle Beach price target lowered to $20 from $40 at Lake Street
Lake Street analyst Mark Argento lowered his price target for Turtle Beach to $20 from $40 after the company's fiscal 2019 guidance came in below expectations. While the revenue guidance midpoint of $244M was in line with consensus, ~$22M of that revenue is expected to come from the Roccat acquisition, Argento tells investors in a research note. The analyst, however, keeps a Buy rating on Turtle Beach.
03/15/19
DADA
03/15/19
NO CHANGE
Target $23
DADA
Buy
Turtle Beach price target lowered to $23 from $26 at DA Davidson
DA Davidson analyst Tom Forte lowered his price target on Turtle Beach to $23 from $26, saying that while its Q1 guidance and the pending acquisition of Roccat aimed to expand its product line were encouraging, its FY19 earnings outlook was disappointing. Excluding the $20M-$24M in revenue contribution from Roccat, the analyst sees the management's $220M-$224M outlook implying a 22%-24% decline, which is worse than his expected 10% slowdown and the initial consensus calling for a 15% slide. Forte is calling the outlook as overly conservative however and keeps his Buy rating on Turtle Beach given its "accelerating refresh cycle and more freemium title releases such as Apex Legends."
05/09/19
DADA
05/09/19
NO CHANGE
Target $26
DADA
Buy
Turtle Beach price target raised to $26 from $23 at DA Davidson
DA Davidson analyst Tom Forte raised his price target on Turtle Beach to $26 and kept his Buy rating, saying the company's Q1 revenue and earnings beat were "extremely" encouraging. The analyst anticipated further sales upside for FY19 to come from more gaming publishers releasing "freemium" titles and a faster refresh cycle for Turtle Beach gaming accessory products.
04/09/19
DADA
04/09/19
NO CHANGE
Target $23
DADA
Buy
Turtle Beach can exploit secular gaming shift, says DA Davidson
DA Davidson analyst Tom Forte kept his Buy rating and $23 price target on Turtle Beach after meeting with its CEO and CFO last week, saying the discussions increased his confidence that the company can "exploit the secular shifts in gaming" toward esports and the freemium model while generating "significant free cash flow". The analyst is also positive on the company's pending ROCCAT deal, which he expects to close in May, and "leverage both companies' relative geographic distribution strengths". Forte adds that the shift to freemium could be a catalyst for Turtle Beach in that gamers will have a larger budget to spend on gaming accessories by not having to pay for video games.
NTDOY Nintendo
$0.00

(0.00%)

07/18/18
SBSH
07/18/18
NO CHANGE
Target $300
SBSH
Buy
Nvidia can selloff near-term on graphics commentary, says Citi
Citi analyst Atif Malik says his recent supply chain checks indicate discrete graphics gaming demand is expected to remain sluggish thru the September quarter due to a "sharp decline" in mining related demand on falling cryptocurrency prices, channel distributors and partners waiting for Nvidia's (NVDA) new Turing gaming card launch in the October quarter, and weak gaming console sales at Microsoft (MSFT) offset by the Nintendo (NTDOY) Switch. The analyst lowered his July and October quarter estimates for Nvidia to bring them in-line with consensus. He thinks the stock can selloff in the near-term on weaker than expected graphics commentary from TSMC (TSM), who reports on July 19, and AMD (AMD), who reports on July 25. Malik, however, keeps a Buy rating on Nvidia with a $300 price target. He believes his long-term thesis on the shares remains intact.
06/11/19
MACQ
06/11/19
INITIATION
MACQ
Outperform
Nintendo initiated with an Outperform at Macquarie
Macquarie analyst Damian Thong initiated Nintendo with an Outperform rating earlier.
09/06/18
BARD
09/06/18
NO CHANGE
Target $14
BARD
Outperform
GameStop strong hardware sales offset pre-owned and software decline, says Baird
Baird analyst Colin Sebastian kept his Outperform rating and $14 price target on GameStop (GME) after its "in-line" Q2 results, where "strong new hardware sales and improving Tech Brands segment profitability" offset the declines in the pre-owned and software segments. The analyst adds that the revenue beat was driven by the ongoing demand for Nintendo (NTDOY) Switch and Xbox One consoles, while noting that the comps decline of -0.5% was better than the expected -3.7% decrease.
11/26/18
WEDB
11/26/18
NO CHANGE
WEDB
Sony appeared to be video game hardware winner on Black Friday, says Wedbush
Wedbush analyst Michael Pachter notes that each of the four game retailers he tracked, namely Best Buy (BBY), GameStop (GME), Target (TGT) and Walmart (WMT) offered the Marvel's Spider-Man PlayStation 4 Bundle that included a slim PS4 with a 1TB hard drive and Sony's (SNE) Marvel's Spider-Man for $199.99, as well as the Microsoft's (MSFT) Xbox One S Minecraft Creators Bundle that included an Xbox One S with a 1TB hard drive, a Minecraft full game download, the Starter Pack, the Creators Pack, and 1,000 Minecoins for $199.99. Nintendo's (NTDOY) primary hardware offering was less compelling given that it was priced at the console's standard MSRP, he adds. The only sell-out that the analyst saw over Black Friday was the primary PS4 deal. Pachter expects the Black Friday deals to eventually translate into permanent price cuts for the base PS4 and Xbox One, possibly by this Christmas.

TODAY'S FREE FLY STORIES

GM

General Motors

$35.66

-0.36 (-1.00%)

18:49
06/16/19
06/16
18:49
06/16/19
18:49
Periodicals
GM won't deploy self-driving fleet until safer than human driver, Axios reports »

General Motors CEO Mary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 12

    Aug

T

AT&T

$32.36

0.06 (0.19%)

, CMCSA

Comcast

$42.31

0.62 (1.49%)

17:58
06/16/19
06/16
17:58
06/16/19
17:58
On The Fly
Box Office Battle: 'Men in Black: International' wins weekend with just $28.5M »

Sony’s (SNE) "Men in…

T

AT&T

$32.36

0.06 (0.19%)

CMCSA

Comcast

$42.31

0.62 (1.49%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$51.42

1.735 (3.49%)

LGF.A

Lionsgate

$12.22

-0.85 (-6.50%)

DIS

Disney

$141.64

-0.09 (-0.06%)

VIAB

Viacom

$29.38

-0.28 (-0.94%)

VIA

Viacom

$34.61

0.14 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 24

    Jul

  • 25

    Jul

  • 08

    Aug

  • 08

    Aug

GS

Goldman Sachs

$191.71

0.24 (0.13%)

17:43
06/16/19
06/16
17:43
06/16/19
17:43
Periodicals
Goldman Sachs combining private-investing units, WSJ reports »

Goldman Sachs is pulling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 16

    Jul

DB

Deutsche Bank

$6.79

-0.07 (-1.02%)

17:38
06/16/19
06/16
17:38
06/16/19
17:38
Periodicals
Deutsche Bank to set up EUR50B bad bank, Financial Times reports »

Deutsche Bank is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$87.10

(0.00%)

16:35
06/16/19
06/16
16:35
06/16/19
16:35
Periodicals
Tires blow on United jet during Newark airport landing, Reuters reports »

Tires on a United…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$87.83

-0.48 (-0.54%)

16:33
06/16/19
06/16
16:33
06/16/19
16:33
Periodicals
Target registers back online after outage blamed on tech issue, Reuters says »

Target said its payment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$46.18

-0.54 (-1.16%)

16:30
06/16/19
06/16
16:30
06/16/19
16:30
Hot Stocks
Intel announces program for Israeli startups targeting tech inflections »

Intel announced a program…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 25

    Jul

BA

Boeing

$347.19

-1.54 (-0.44%)

16:27
06/16/19
06/16
16:27
06/16/19
16:27
Periodicals
Boeing says will take time to rebuild customer confidence, Reuters reports »

The head of Boeing said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 09

    Jul

GS

Goldman Sachs

$191.71

0.24 (0.13%)

16:19
06/16/19
06/16
16:19
06/16/19
16:19
Periodicals
Goldman Sachs skeptical of 'insurance' rate cuts from Fed, Reuters says »

Goldman Sachs economists…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 16

    Jul

BA

Boeing

$347.19

-1.54 (-0.44%)

16:16
06/16/19
06/16
16:16
06/16/19
16:16
Periodicals
Trials nearing for Boeing 737 Max fix, WSJ reports »

The Federal Aviation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 09

    Jul

ESLT

Elbit Systems

$154.55

0.55 (0.36%)

13:41
06/16/19
06/16
13:41
06/16/19
13:41
Hot Stocks
Elbit Systems awarded $50M contract »

Elbit Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$176.09

-0.74 (-0.42%)

13:40
06/16/19
06/16
13:40
06/16/19
13:40
Hot Stocks
Amgen announces BLINCYTO five-year overall survival data »

Amgen announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

SILK

Silk Road Medical

$44.80

-0.95 (-2.08%)

13:35
06/16/19
06/16
13:35
06/16/19
13:35
Hot Stocks
Silk Road Medical announces final results for ROADSTER-2 study »

Silk Road Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 26

    Aug

EDIT

Editas Medicine

$21.72

-0.78 (-3.47%)

13:30
06/16/19
06/16
13:30
06/16/19
13:30
Hot Stocks
Editas presents pre-clinical data in Sickle Cell Disease, Beta-Thalassemia »

Editas Medicine announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNSS

Sunesis

$0.90

-0.055 (-5.79%)

13:28
06/16/19
06/16
13:28
06/16/19
13:28
Hot Stocks
Sunesis announces preliminary data from Phase 1b/2 trial of Vecabrutinib »

Sunesis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

APLS

Apellis

$21.22

-0.14 (-0.66%)

13:23
06/16/19
06/16
13:23
06/16/19
13:23
Hot Stocks
Apellis presents data from ongoing Phase 2 PLAUDIT study of APL-2 »

Apellis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

FTSV

Forty Seven

$10.55

-0.02 (-0.19%)

13:16
06/16/19
06/16
13:16
06/16/19
13:16
Hot Stocks
Forty Seven announces data from Phase 1b/2 trial of 5F9 in combo with Rituximab »

Forty Seven announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$39.68

-0.23 (-0.58%)

13:06
06/16/19
06/16
13:06
06/16/19
13:06
Hot Stocks
AstraZeneca announces results from interim analysis of Phase 2 ASCEND trial »

AstraZeneca announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

STRO

Sutro Biopharma

$11.17

-0.34 (-2.95%)

13:02
06/16/19
06/16
13:02
06/16/19
13:02
Hot Stocks
Sutro Biopharma announces interim Phase 1 safety data for STRO-001 »

Sutro Biopharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPMC

Blueprint Medicines

$90.65

-0.35 (-0.38%)

12:59
06/16/19
06/16
12:59
06/16/19
12:59
Hot Stocks
Blueprint Medicines presents updated EXPLORER trial data for Avapritinib »

Blueprint Medicines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

INCY

Incyte

$77.76

1.385 (1.81%)

12:52
06/16/19
06/16
12:52
06/16/19
12:52
Hot Stocks
Incyte announced results from Phase 2 study of Ruxolitinib cream in vitiligo »

Incyte announces 24-week…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

, INCY

Incyte

$77.76

1.385 (1.81%)

04:55
06/16/19
06/16
04:55
06/16/19
04:55
Conference/Events
European Hematology Association to hold a conference »

24th EHA Congress 2019…

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

INCY

Incyte

$77.76

1.385 (1.81%)

ARQL

ArQule

$8.17

1.88 (29.89%)

AMGN

Amgen

$176.09

-0.74 (-0.42%)

ALXN

Alexion

$117.94

0.65 (0.55%)

AGIO

Agios Pharmaceuticals

$47.97

-1.78 (-3.58%)

AZN

AstraZeneca

$39.68

-0.23 (-0.58%)

BLUE

Bluebird Bio

$117.57

-6.33 (-5.11%)

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

CELG

Celgene

$96.49

0.07 (0.07%)

NVS

Novartis

$89.52

-0.07 (-0.08%)

NSTG

NanoString

$25.96

0.45 (1.76%)

KPTI

Karyopharm

$5.71

-0.04 (-0.70%)

JAZZ

Jazz Pharmaceuticals

$130.43

0.28 (0.22%)

GSK

GlaxoSmithKline

$40.12

0.015 (0.04%)

GILD

Gilead

$66.38

-0.62 (-0.93%)

DSNKY

Daiichi Sankyo

$0.00

(0.00%)

PFE

Pfizer

$42.75

0.24 (0.56%)

PTLA

Portola Pharmaceuticals

$25.78

-0.31 (-1.19%)

QGEN

Qiagen

$39.52

-0.07 (-0.18%)

RHHBY

Roche

$0.00

(0.00%)

RIGL

Rigel Pharmaceuticals

$2.06

-0.06 (-2.83%)

SNY

Sanofi

$42.46

-0.225 (-0.53%)

SGEN

Seattle Genetics

$68.67

-0.33 (-0.48%)

STML

Stemline

$14.20

0.12 (0.85%)

VSTM

Verastem

$1.39

0.125 (9.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 18

    Jun

  • 20

    Jun

  • 20

    Jun

  • 20

    Jun

  • 21

    Jun

  • 23

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 28

    Jun

  • 06

    Jul

  • 25

    Jul

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 26

    Aug

  • 28

    Aug

  • 29

    Aug

  • 02

    Sep

  • 03

    Sep

  • 16

    Sep

  • 04

    Nov

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

, GRUB

GrubHub

$70.15

-2.76 (-3.79%)

13:28
06/15/19
06/15
13:28
06/15/19
13:28
Periodicals
Amazon exit gives GrubHub stock boost, Barron's says »

Amazon (AMZN) is…

AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

GRUB

GrubHub

$70.15

-2.76 (-3.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 10

    Jul

ABC

AmerisourceBergen

$85.01

-1.46 (-1.69%)

, CAH

Cardinal Health

$44.16

-1.13 (-2.50%)

13:20
06/15/19
06/15
13:20
06/15/19
13:20
Periodicals
McKesson, Cardinal Health looking like bargains, Barron's says »

Investors have halved the…

ABC

AmerisourceBergen

$85.01

-1.46 (-1.69%)

CAH

Cardinal Health

$44.16

-1.13 (-2.50%)

MCK

McKesson

$133.19

-1.7 (-1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

RTN

Raytheon

$177.38

0.195 (0.11%)

, UTX

United Technologies

$125.30

0.45 (0.36%)

13:09
06/15/19
06/15
13:09
06/15/19
13:09
Periodicals
United Technologies, Raytheon stocks looking cheap, Barron's says »

Shares of United…

RTN

Raytheon

$177.38

0.195 (0.11%)

UTX

United Technologies

$125.30

0.45 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 17

    Jun

  • 17

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.